Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma

Zuo,Chao‑Hui; Qiu,Xiao‑Xin; Ouyang,Yong‑Zhong; Zhang,Di; Xiao,Hua; Mo,Sheng‑Chuan; Tan,Chun‑Qi; Tang,Ming; Zhu,Hai‑Zhen

doi:10.3892/mco.2014.309

September-October 2014 Volume 2 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

September-October 2014 Volume 2 Issue 5

Full Size Image

Article

Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma

Authors:
- Chao‑Hui Zuo
- Xiao‑Xin Qiu
- Yong‑Zhong Ouyang
- Di Zhang
- Hua Xiao
- Sheng‑Chuan Mo
- Chun‑Qi Tan
- Ming Tang
- Hai‑Zhen Zhu
View Affiliations / Copyright

Affiliations: Department of Gastroduodenal and Pancreatic Surgery, Hunan Provincial Tumor Hospital and Affiliated Tumor Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan 410013, P.R. China, Liver Cancer Translational Medicine Center of Hunan University and Hunan Provincial Tumor Hospital, Changsha, Hunan 410082, P.R. China
Pages: 833-838
|
Published online on: June 6, 2014

https://doi.org/10.3892/mco.2014.309
Expand metrics +

Abstract

Mesohepatectomy is considered a feasible option for patients with centrally located hepatocellular carcinoma (HCC). However, mesohepatectomy is a technically demanding and less frequently used procedure. In this study, we summarized the surgical experience and evaluated the clinical outcomes of mesohepatectomy in 24 patients with centrally located HCC. Of these patients, 9 were treated with hepatectomy of Couinaud's segments IV, V and VIII with concurrent cholecystectomy; 8 underwent resection of segments IVb, V and VIII, including 7 patients who also received a cholecystectomy; 4 underwent hepatectomy of segments IVa, V and VIII; and 3 patients were treated with hepatectomy of segments I, IV, V and VIII, with concurrent cholecystectomy. The Pringle maneuver was used on 17 patients during hepatectomy. Total hepatic vascular exclusion (HVE) was performed on 3 patients and HVE was not used on 4 patients. The average mesohepatectomy operative time was 238 min and the average intraoperative blood loss was 480 ml (200‑2,200 ml). There was no intraoperative mortality and the postoperative morbidity rate was 25% (6/24). The 1‑ and 3‑year overall survival rates were 76 and 46%, respectively. Therefore, mesohepatectomy is a safe and effective surgical procedure for the treatment of centrally located HCC and HVE during mesohepatectomy for centrally located HCC is crucial to the success of the operation and postoperative patient recovery.

View Figures

View References

1	Hu RH, Lee PH, Chang YC, Ho MC and Yu SC: Treatment of centrally located hepatocellular carcinoma with central hepatectomy. Surgery. 133:251–256. 2003. View Article : Google Scholar : PubMed/NCBI
2	Curley SA, Izzo F, Ellis LM, Nicolas Vauthey J and Vallone P: Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis. Ann Surg. 232:381–391. 2000. View Article : Google Scholar : PubMed/NCBI
3	McGahan JP, Brock JM, Tesluk H, Gu WZ, Schneider P and Browning PD: Hepatic ablation with use of radio-frequency electrocautery in the animal model. J Vasc Interv Radiol. 3:291–297. 1992. View Article : Google Scholar : PubMed/NCBI
4	Tateishi R, Shiina S, Teratani T, et al: Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer. 103:1201–1209. 2005.
5	Lang H, Broelsch CE, Bertona C and Bourquain H: Extended left hepatectomy with an inferior right liver vein: improved operation planning by 3-D reconstruction and computer-assisted imaging. J Am Coll Surg. 205:626–627. 2007. View Article : Google Scholar : PubMed/NCBI
6	Poon RT, Fan ST, Lo CM, et al: Extended hepatic resection for hepatocellular carcinoma in patients with cirrhosis: is it justified? Ann Surg. 236:602–611. 2002. View Article : Google Scholar : PubMed/NCBI
7	Chedid AD, Chedid MF, Kruel CR, Girardi FM and Krue CD: Extended right hepatectomy with total caudate lobe resection and biliary tree resection for a large colorectal liver metastasis involving both the right and left hepatic lobes and the umbilical fissure: a case report. Am Surg. 71:447–449. 2005.
8	Scudamore CH, Buczkowski AK, Shayan H, Ho SG, Legiehn GM, Chung SW and Owen DA: Mesohepatectomy. Am J Surg. 179:356–360. 2000. View Article : Google Scholar
9	Vauthey JN, Pawlik TM, Abdalla EK, et al: Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg. 239:722–730; discussion 730–732. 2004. View Article : Google Scholar : PubMed/NCBI
10	Mehrabi A, Mood ZA, Roshanaei N, et al: Mesohepatectomy as an option for the treatment of central liver tumors. J Am Coll Surg. 207:499–509. 2008. View Article : Google Scholar : PubMed/NCBI
11	Sotiropoulos GC, Lang H, Molmenti EP, Kaiser GM, Paul A and Broelsch CE: Partial or complete mesohepatectomy combined with resection of the hilar bifurcation in cases of Klatskin tumors: a reasonable strategy? Am J Surg. 198:297–298. 2009. View Article : Google Scholar
12	Wu CC, Ho WL, Chen JT, et al: Mesohepatectomy for centrally located hepatocellular carcinoma: an appraisal of a rare procedure. J Am Coll Surg. 188:508–515. 1999. View Article : Google Scholar : PubMed/NCBI
13	Riaz A, Ryu RK, Kulik LM, et al: Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression and survival. J Clin Oncol. 27:5734–5742. 2009. View Article : Google Scholar
14	Ishii H, Ogino S, Ikemoto K, et al: Mesohepatectomy with total caudate lobectomy of the liver for hepatocellular carcinoma. World J Surg Oncol. 11:822013. View Article : Google Scholar : PubMed/NCBI
15	Kishi Y, Hasegawa K, Sugawara Y and Kokudo N: Hepatocellular carcinoma: current management and future development-improved outcomes with surgical resection. Int J Hepatol. 2011:7281032011. View Article : Google Scholar : PubMed/NCBI
16	Yang Y, Fu SY, Lau WY, et al: Selective main portal vein clamping to minimize the risk of recurrence after curative liver resection for hepatocellular carcinoma. Hepatogastroenterology. 59:1560–1565. 2012.PubMed/NCBI
17	Chang YC, Nagasue N, Chen CS and Lin XZ: Simplified hepatic resections with the use of a Chang’s needle. Ann Surg. 243:169–172. 2006.PubMed/NCBI
18	Soulez G, Lerouge S, Allard L, et al: Vulnerable carotid atherosclerotic plaque creation in a swine model: evaluation of stenosis creation using absorbable and permanent suture in a diabetic dyslipidemic model. J Vasc Interv Radiol. 23:1700–1708. 2012. View Article : Google Scholar

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Mesohepatectomy for the treatment of patients with centrally located hepatocellular carcinoma

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Related Articles